Vimarsana
Biggest News Aggregation in the World

Life Interference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Interference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Interference Today - Breaking & Trending Today

FDA Approves Pfizer, OPKO's Once Weekly Ngenla for Human Growth Deficiency in Pediatric Patients - Vimarsana News

FDA Approves Pfizer, OPKO's Once Weekly Ngenla for Human Growth Deficiency in Pediatric Patients

Published: June 29, 2023

Somatrogon-ghla (Ngenla; Pfizer Inc, OPKO Health Inc) is a subcutaneous injection that is administered once weekly via a device allowing for titration based on patients’ needs.

Source: pharmacytimes.com
Related Topics:
United StatesJoel SteelmanPfizer IncHealth IncCook Children Health Care SystemEuropean Union Member StatesCook ChildrenHealth Care SystemLife Interference
OPKO Health : Immediate Report | MarketScreener - Vimarsana News

OPKO Health : Immediate Report | MarketScreener

Published: February 15, 2022

Pfizer and OPKO's Once-Weekly NGENLATM Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency NEW YORK... | February 15, 2022

Source: marketscreener.com
Related Topics:
United StatesReda GuihaPhillip FrostInternational DevelopedPfizer IncEuropean UnionEuropean CommissionHealth IncInjection Receives Marketing AuthorizationPediatric Growth Hormone DeficiencyRegional PresidentInternational Developed MarketsPfizer RareChief Executive OfficerInjection StudiesLife InterferenceOpko HealthNc Stock ExchangePress ReleaseEw Opk Us68375n1037